Carbuncle

Obesity & Type 2 Diabetes: An Expert Discussion

Daily Dose: Semaglutide Cuts CV Risk by 20% in Adults with Obesity, CVD and Without DM

Respiratory Tripledemic 2022-23: An Expert Recap

It's High Time to Retire NAFLD: Multinational Liver Societies Explain

Daily Dose: Possible Impact of RSVpreF Maternal Vaccine for RSV Prevention in Infants

Widening Gender Gap in Life Expectancy Primarily Driven by COVID-19 and Drug Overdose Crisis, According to New Research

Obesity & Type 2 Diabetes: An Expert Discussion

Daily Dose: Semaglutide Cuts CV Risk by 20% in Adults with Obesity, CVD and Without DM

Respiratory Tripledemic 2022-23: An Expert Recap

It's High Time to Retire NAFLD: Multinational Liver Societies Explain

Daily Dose: Possible Impact of RSVpreF Maternal Vaccine for RSV Prevention in Infants

Widening Gender Gap in Life Expectancy Primarily Driven by COVID-19 and Drug Overdose Crisis, According to New Research

Obesity & Type 2 Diabetes: An Expert Discussion

Daily Dose: Semaglutide Cuts CV Risk by 20% in Adults with Obesity, CVD and Without DM

Respiratory Tripledemic 2022-23: An Expert Recap

It's High Time to Retire NAFLD: Multinational Liver Societies Explain

Daily Dose: Possible Impact of RSVpreF Maternal Vaccine for RSV Prevention in Infants

Widening Gender Gap in Life Expectancy Primarily Driven by COVID-19 and Drug Overdose Crisis, According to New Research

Related Content

Widening Gender Gap in Life Expectancy Primarily Driven by COVID-19 and Drug Overdose Crisis / Image credit: ©wissanustock/AdobeStock

Obesity & Type 2 Diabetes: An Expert Discussion

Investigators found that the gender life expectancy gap increased 0.23 years from 2010 to 2019 and 0.70 years from 2019 to 2021.

Daily Dose: Semaglutide Cuts CV Risk by 20% in Adults with Obesity, CVD and Without DM

Podcast

In our latest episode, 2 obesity experts discuss the importance of early intervention to reduce risk for complications, suggestions for managing patients in primary care, and more.

Respiratory Tripledemic 2022-23: An Expert Recap

Your daily dose of the clinical news you may have missed.

It's High Time to Retire NAFLD: Multinational Liver Societies Explain

Podcast

William Schaffner, MD, medical director of the NFID, provides an expert recap of the 2022-2023 respiratory virus season for primary care clinicians.

metabolic dysfunction-associated steatotic liver disease (MASLD) / Image Credit liver disease © Kateryna_Kon/stock.adobe.com

Daily Dose: Possible Impact of RSVpreF Maternal Vaccine for RSV Prevention in Infants

NAFLD, a term coined in the mid-nineteenth century but never an accurate name for the diseases it now stands for, was ready to go, agreed international experts.